Rankings
▼
Calendar
ELAN Q3 2017 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q3 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$697M
Gross Profit
$321M
46.0% margin
Operating Income
$13M
1.8% margin
Net Income
-$21M
-3.0% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
-3.0%
Cash Flow
Operating Cash Flow
$77M
Free Cash Flow
$55M
Stock-Based Comp.
$6M
← FY 2017
All Quarters
Q4 2017 →
